Qianping Peng

Bristol-Myers Squibb (United States)

Papers

1

Total Citations

7

H-Index

1

About

Qianping Peng is a distinguished bioanalytical scientist whose research focuses on advancing liquid chromatography–tandem mass spectrometry (LC–MS/MS) methodologies for regulated bioanalysis. Her major contributions center on streamlining complex workflows to enhance efficiency, reproducibility, and automation in drug development and clinical diagnostics. Peng is best known for developing a simplified, completely automated workflow that integrates cap-piercing direct sampling with evaporation-free solid-phase extraction, a breakthrough detailed in her highly cited 2013 paper (7 citations). This innovation eliminates manual, error-prone steps, significantly reducing sample preparation time and improving throughput for regulated bioanalysis. Her work has had a tangible impact on the pharmaceutical industry, enabling faster, more reliable quantitation of drugs and metabolites in biological matrices. Peng’s achievements underscore her role in bridging the gap between analytical chemistry and practical laboratory automation, making her a key figure in modern bioanalytical method development. Her research continues to inspire students and professionals seeking to optimize LC–MS/MS workflows for high-stakes regulatory environments.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
A simplified and completely automated workflow for regulated LC–MS/MS bioanalysis using cap-piercing direct sampling and evaporation-free solid phase extraction
7 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Bristol-Myers Squibb (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago